Author

Shuaizhi Li

University of Arizona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Samuel K. CamposiD· 2 shared Advait JeevanandamiD· 1 shared Andrew L. PaekiD· 1 shared Briana A. Guzman· 1 shared Cameron Holberg· 1 shared Carly R. CabeliD· 1 shared Chonlarat WichaiditiD· 1 shared Curtis A. ThorneiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Samuel K. CamposORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors.

Carly R. Cabel, Briana A. Guzman, Elaheh Alizadeh, Shuaizhi Li, Cameron Holberg, Chonlarat Wichaidit, Darren A. Cusanovich, Andrew L. Paek, Gregory R. J. Thatcher, Koenraad Van Doorslaer, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, James E. Crowe, Robert H. Carnahan, , Curtis A. Thorne

This study uses high-throughput screens in human cells with authentic SARS-CoV-2 virus to identify neutralizing monoclonal antibodies and kinase inhibitors with minimal host toxicity.

Frontiers in Cell and Developmental Biology · May 22, 2025Peer-reviewedPharmacology & Toxicology

A Peptide Derived from Sorting Nexin 1 Inhibits HPV16 Entry, Retrograde Trafficking, and L2 Membrane Spanning

Shuaizhi Li, Zachary L. Williamson, Matthew A. Christofferson, Advait Jeevanandam, Samuel K. Campos

This study shows that the peptide SNX1.3 inhibits HPV16 entry, retrograde trafficking, and L2 membrane spanning, without affecting cell proliferation or post-Golgi trafficking.

Tumour Virus Research · Jun 21, 2024Peer-reviewedMicrobiology